Advertisement
Screener

Neogen Corporation (NEOG) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

Neogen Corporation Research and Development Expense

Neogen Corporation (NEOG) reported Research and Development Expense of $18.40 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-30

  • Neogen Corporation research and development expense for the quarter ending 2026-05-31 was $4.90M, a 22.22% decline year-over-year.
  • Neogen Corporation research and development expense for the quarter ending 2026-02-28 was $3.80M, a 15.56% decline year-over-year.
  • Neogen Corporation research and development expense for the quarter ending 2025-11-30 was $4.56M, a 10.67% decline year-over-year.
  • Neogen Corporation research and development expense for the quarter ending 2025-08-31 was $5.13M, a 1.42% decline year-over-year.
  • Neogen Corporation research and development expense for fiscal 2026 was $18.40M, a 12.80% decline from fiscal 2025.
  • Neogen Corporation research and development expense for fiscal 2025 was $21.10M, a 6.22% decline from fiscal 2024.
  • Neogen Corporation research and development expense for fiscal 2024 was $22.50M, a 13.59% decline from fiscal 2023.
  • Neogen Corporation research and development expense for fiscal 2023 was $26.04M, a 52.73% increase from fiscal 2022.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2026-05-31$4.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30
$8.70M
derived: sum of 2 quarters · filed 2026-07-30
$13.26M
derived: sum of 3 quarters · filed 2026-07-30
$18.40M
10-K · filed 2026-07-30
2026-02-28$3.80M
10-Q · filed 2026-04-09
$8.36M
derived: sum of 2 quarters · filed 2026-04-09
$13.50M
10-Q · filed 2026-04-09
$19.79M
derived: sum of 4 quarters · filed 2026-07-30
2025-11-30$4.56M
10-Q · filed 2026-01-08
$9.69M
10-Q · filed 2026-01-08
$15.99M
derived: sum of 3 quarters · filed 2026-07-30
$20.49M
derived: sum of 4 quarters · filed 2026-07-30
2025-08-31$5.13M
10-Q · filed 2025-10-09
$11.43M
derived: sum of 2 quarters · filed 2026-07-30
$15.93M
derived: sum of 3 quarters · filed 2026-07-30
$21.03M
derived: sum of 4 quarters · filed 2026-07-30
2025-05-31$6.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30
$10.80M
derived: sum of 2 quarters · filed 2026-07-30
$15.91M
derived: sum of 3 quarters · filed 2026-07-30
$21.10M
10-K · filed 2026-07-30
$21.09M
10-K · filed 2025-07-30
2025-02-28$4.50M
10-Q · filed 2026-04-09
$4.47M
10-Q · filed 2025-04-09
$9.61M
derived: sum of 2 quarters · filed 2026-04-09
$14.80M
10-Q · filed 2026-04-09
$14.78M
10-Q · filed 2025-04-09
$19.98M
derived: sum of 4 quarters · filed 2026-07-30
2024-11-30$5.11M
10-Q · filed 2026-01-08
$10.31M
10-Q · filed 2026-01-08
$15.48M
derived: sum of 3 quarters · filed 2026-07-30
$20.33M
derived: sum of 4 quarters · filed 2026-07-30
2024-08-31$5.20M
10-Q · filed 2025-10-09
$10.37M
derived: sum of 2 quarters · filed 2026-07-30
$15.22M
derived: sum of 3 quarters · filed 2026-07-30
$20.98M
derived: sum of 4 quarters · filed 2026-07-30
2024-05-31$5.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30
$10.02M
derived: sum of 2 quarters · filed 2026-07-30
$15.78M
derived: sum of 3 quarters · filed 2026-07-30
$22.50M
10-K · filed 2026-07-30
$22.48M
10-K · filed 2024-07-30
2024-02-29$4.85M
10-Q · filed 2025-04-09
$10.61M
derived: sum of 2 quarters · filed 2025-04-09
$17.33M
10-Q · filed 2025-04-09
$24.39M
derived: sum of 4 quarters · filed 2025-07-30
2023-11-30$5.76M
10-Q · filed 2025-01-15
$12.48M
10-Q · filed 2025-01-15
$19.53M
derived: sum of 3 quarters · filed 2025-07-30
$26.79M
derived: sum of 4 quarters · filed 2025-07-30
2023-08-31$6.72M
10-Q · filed 2024-10-10
$13.78M
derived: sum of 2 quarters · filed 2025-07-30
$21.03M
derived: sum of 3 quarters · filed 2025-07-30
$27.88M
derived: sum of 4 quarters · filed 2025-07-30
2023-05-31$7.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30
$14.31M
derived: sum of 2 quarters · filed 2025-07-30
$21.16M
derived: sum of 3 quarters · filed 2025-07-30
$26.04M
10-K · filed 2025-07-30
2023-02-28$7.26M
10-Q · filed 2024-04-09
$14.10M
derived: sum of 2 quarters · filed 2024-04-09
$18.98M
10-Q · filed 2024-04-09
$22.82M
derived: sum of 4 quarters · filed 2024-07-30
2022-11-30$6.85M
10-Q · filed 2024-01-09
$11.73M
10-Q · filed 2024-01-09
$15.56M
derived: sum of 3 quarters · filed 2024-07-30
$20.12M
derived: sum of 4 quarters · filed 2024-07-30
2022-08-31$4.88M
10-Q · filed 2023-10-10
$8.71M
derived: sum of 2 quarters · filed 2024-07-30
$13.27M
derived: sum of 3 quarters · filed 2024-07-30
$17.61M
derived: sum of 4 quarters · filed 2024-07-30
2022-05-31$3.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30
$8.39M
derived: sum of 2 quarters · filed 2024-07-30
$12.72M
derived: sum of 3 quarters · filed 2024-07-30
$17.05M
10-K · filed 2024-07-30
2022-02-28$4.56M
10-Q · filed 2023-04-04
$8.89M
derived: sum of 2 quarters · filed 2023-04-04
$13.22M
10-Q · filed 2023-04-04
$17.30M
derived: sum of 4 quarters · filed 2023-08-15
2021-11-30$4.33M
10-Q · filed 2023-01-09
$8.66M
10-Q · filed 2023-01-09
$12.73M
derived: sum of 3 quarters · filed 2023-08-15
$16.97M
derived: sum of 4 quarters · filed 2023-08-15
2021-08-31$4.33M
10-Q · filed 2022-09-30
$8.40M
derived: sum of 2 quarters · filed 2023-08-15
$12.64M
derived: sum of 3 quarters · filed 2023-08-15
$16.69M
derived: sum of 4 quarters · filed 2023-08-15
2021-05-31$4.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15
$8.31M
derived: sum of 2 quarters · filed 2023-08-15
$12.37M
derived: sum of 3 quarters · filed 2023-08-15
$16.25M
10-K · filed 2023-08-15
2021-02-28$4.24M
10-Q · filed 2022-04-01
$8.29M
derived: sum of 2 quarters · filed 2022-04-01
$12.17M
10-Q · filed 2022-04-01
$15.63M
derived: sum of 4 quarters · filed 2022-07-27
2020-11-30$4.06M
10-Q · filed 2021-12-30
$7.93M
10-Q · filed 2021-12-30
$11.39M
derived: sum of 3 quarters · filed 2022-07-27
$15.21M
derived: sum of 4 quarters · filed 2022-07-27
2020-08-31$3.88M
10-Q · filed 2021-09-30
$7.34M
derived: sum of 2 quarters · filed 2022-07-27
$11.16M
derived: sum of 3 quarters · filed 2022-07-27
$14.94M
derived: sum of 4 quarters · filed 2022-07-27
2020-05-31$3.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27
$7.28M
derived: sum of 2 quarters · filed 2022-07-27
$11.06M
derived: sum of 3 quarters · filed 2022-07-27
$14.75M
10-K · filed 2022-07-27
2020-02-29$3.82M
10-Q · filed 2021-03-31
$7.60M
derived: sum of 2 quarters · filed 2021-03-31
$11.29M
10-Q · filed 2021-03-31
$14.86M
derived: sum of 4 quarters · filed 2021-07-30
2019-11-30$3.78M
10-Q · filed 2020-12-29
$7.47M
10-Q · filed 2020-12-29
$11.04M
derived: sum of 3 quarters · filed 2021-07-30
$14.29M
derived: sum of 4 quarters · filed 2021-07-30
2019-08-31$3.69M
10-Q · filed 2020-09-30
$7.26M
derived: sum of 2 quarters · filed 2021-07-30
$10.51M
derived: sum of 3 quarters · filed 2021-07-30
$13.67M
derived: sum of 4 quarters · filed 2021-07-30
2019-05-31$3.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30
$6.82M
derived: sum of 2 quarters · filed 2021-07-30
$9.99M
derived: sum of 3 quarters · filed 2021-07-30
$12.80M
10-K · filed 2021-07-30
2019-02-28$3.25M
10-Q · filed 2020-04-03
$6.42M
derived: sum of 2 quarters · filed 2020-04-03
$9.23M
10-Q · filed 2020-04-03
$11.19M
derived: sum of 4 quarters · filed 2020-07-30
2018-11-30$3.17M
10-Q · filed 2018-12-28
$5.99M
10-Q · filed 2019-12-27
$7.94M
derived: sum of 3 quarters · filed 2020-07-30
$10.78M
derived: sum of 4 quarters · filed 2020-07-30
2018-08-31$2.82M
10-Q · filed 2019-09-26
$4.77M
derived: sum of 2 quarters · filed 2020-07-30
$7.61M
derived: sum of 3 quarters · filed 2020-07-30
$10.58M
derived: sum of 4 quarters · filed 2020-07-30
2018-05-31$1.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30
$4.79M
derived: sum of 2 quarters · filed 2020-07-30
$7.76M
derived: sum of 3 quarters · filed 2020-07-30
$10.86M
10-K · filed 2020-07-30
2018-02-28$2.84M
10-Q · filed 2019-03-29
$5.80M
derived: sum of 2 quarters · filed 2019-03-29
$8.90M
10-Q · filed 2019-03-29
$11.20M
derived: sum of 4 quarters · filed 2019-07-30
2017-11-30$2.97M
10-Q · filed 2018-12-28
$6.07M
10-Q · filed 2018-12-28
$8.36M
derived: sum of 3 quarters · filed 2019-07-30
$11.00M
derived: sum of 4 quarters · filed 2019-07-30
2017-08-31$3.10M
10-Q · filed 2018-10-05
$5.40M
derived: sum of 2 quarters · filed 2019-07-30
$8.04M
derived: sum of 3 quarters · filed 2019-07-30
$10.80M
derived: sum of 4 quarters · filed 2019-07-30
2017-05-31$2.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-30
$4.94M
derived: sum of 2 quarters · filed 2019-07-30
$7.71M
derived: sum of 3 quarters · filed 2019-07-30
$10.38M
10-K · filed 2019-07-30
2017-02-28$2.64M
10-Q · filed 2018-03-29
$5.41M
derived: sum of 2 quarters · filed 2018-03-29
$8.09M
10-Q · filed 2018-03-29
$10.34M
derived: sum of 4 quarters · filed 2018-07-27
2016-11-30$2.77M
10-Q · filed 2018-01-05
$5.45M
10-Q · filed 2018-01-05
$7.69M
derived: sum of 3 quarters · filed 2018-07-27
$10.14M
derived: sum of 4 quarters · filed 2018-07-27
2016-08-31$2.68M
10-Q · filed 2017-09-29
$4.93M
derived: sum of 2 quarters · filed 2018-07-27
$7.38M
derived: sum of 3 quarters · filed 2018-07-27
$9.99M
derived: sum of 4 quarters · filed 2018-07-27
2016-05-31$2.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-27
$4.70M
derived: sum of 2 quarters · filed 2018-07-27
$7.32M
derived: sum of 3 quarters · filed 2018-07-27
$9.89M
10-K · filed 2018-07-27
2016-02-29$2.45M
10-Q · filed 2017-03-31
$5.07M
derived: sum of 2 quarters · filed 2017-03-31
$7.64M
10-Q · filed 2017-03-31
$9.97M
derived: sum of 4 quarters · filed 2017-07-28
2015-11-30$2.62M
10-Q · filed 2016-12-29
$5.19M
10-Q · filed 2016-12-29
$7.52M
derived: sum of 3 quarters · filed 2017-07-28
$9.89M
derived: sum of 4 quarters · filed 2017-07-28
2015-08-31$2.57M
10-Q · filed 2016-09-30
$4.91M
derived: sum of 2 quarters · filed 2017-07-28
$7.27M
derived: sum of 3 quarters · filed 2017-07-28
$9.74M
derived: sum of 4 quarters · filed 2017-07-28
2015-05-31$2.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28
$4.70M
derived: sum of 2 quarters · filed 2017-07-28
$7.17M
derived: sum of 3 quarters · filed 2017-07-28
$9.58M
10-K · filed 2017-07-28
2015-02-28$2.37M
10-Q · filed 2016-03-31
$4.84M
derived: sum of 2 quarters · filed 2016-03-31
$7.25M
10-Q · filed 2016-03-31
$9.07M
derived: sum of 4 quarters · filed 2016-07-29
2014-11-30$2.47M
10-Q · filed 2016-01-08
$4.88M
10-Q · filed 2016-01-08
$6.71M
derived: sum of 3 quarters · filed 2016-07-29
$8.81M
derived: sum of 4 quarters · filed 2016-07-29
2014-08-31$2.40M
10-Q · filed 2015-09-30
$4.23M
derived: sum of 2 quarters · filed 2016-07-29
$6.34M
derived: sum of 3 quarters · filed 2016-07-29
$8.64M
derived: sum of 4 quarters · filed 2016-07-29
2014-05-31$1.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29
$3.94M
derived: sum of 2 quarters · filed 2016-07-29
$6.24M
derived: sum of 3 quarters · filed 2016-07-29
$8.33M
10-K · filed 2016-07-29
2014-02-28$2.11M
10-Q · filed 2015-04-01
$4.41M
derived: sum of 2 quarters · filed 2015-04-01
$6.50M
10-Q · filed 2015-04-01
$8.38M
derived: sum of 4 quarters · filed 2015-07-30
2013-11-30$2.30M
10-Q · filed 2014-12-30
$4.39M
10-Q · filed 2014-12-30
$6.27M
derived: sum of 3 quarters · filed 2015-07-30
$8.25M
derived: sum of 4 quarters · filed 2015-07-30
2013-08-31$2.09M
10-Q · filed 2014-09-30
$3.97M
derived: sum of 2 quarters · filed 2015-07-30
$5.95M
derived: sum of 3 quarters · filed 2015-07-30
$7.94M
derived: sum of 4 quarters · filed 2015-07-30
2013-05-31$1.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30
$3.86M
derived: sum of 2 quarters · filed 2015-07-30
$5.86M
derived: sum of 3 quarters · filed 2015-07-30
$7.78M
10-K · filed 2015-07-30
2013-02-28$1.98M
10-Q · filed 2014-04-04
$3.98M
derived: sum of 2 quarters · filed 2014-04-04
$5.90M
10-Q · filed 2014-04-04
$7.56M
derived: sum of 4 quarters · filed 2014-07-30
2012-11-30$1.99M
10-Q · filed 2014-01-09
$3.92M
10-Q · filed 2014-01-09
$5.58M
derived: sum of 3 quarters · filed 2014-07-30
$7.33M
derived: sum of 4 quarters · filed 2014-07-30
2012-08-31$1.93M
10-Q · filed 2013-09-30
$3.59M
derived: sum of 2 quarters · filed 2014-07-30
$5.34M
derived: sum of 3 quarters · filed 2014-07-30
$7.05M
derived: sum of 4 quarters · filed 2014-07-30
2012-05-31$1.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30
$3.41M
derived: sum of 2 quarters · filed 2014-07-30
$5.12M
derived: sum of 3 quarters · filed 2014-07-30
$6.64M
10-K · filed 2014-07-30
2012-02-29$1.75M
10-Q · filed 2013-03-28
$3.46M
derived: sum of 2 quarters · filed 2013-03-28
$4.98M
10-Q · filed 2013-03-28
$6.56M
derived: sum of 4 quarters · filed 2013-07-30
2011-11-30$1.71M
10-Q · filed 2012-12-28
$3.22M
10-Q · filed 2012-12-28
$4.81M
derived: sum of 3 quarters · filed 2013-07-30
$6.61M
derived: sum of 4 quarters · filed 2013-07-30
2011-08-31$1.51M
10-Q · filed 2012-09-28
$3.10M
derived: sum of 2 quarters · filed 2013-07-30
$4.90M
derived: sum of 3 quarters · filed 2013-07-30
$6.54M
derived: sum of 4 quarters · filed 2013-07-30
2011-05-31$1.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-30
$3.39M
derived: sum of 2 quarters · filed 2013-07-30
$5.03M
derived: sum of 3 quarters · filed 2013-07-30
$6.83M
10-K · filed 2013-07-30
2011-02-28$1.80M
10-Q · filed 2012-03-30
$3.44M
derived: sum of 2 quarters · filed 2012-03-30
$5.24M
10-Q · filed 2012-03-30
2010-11-30$1.64M
10-Q · filed 2011-12-30
$3.44M
10-Q · filed 2011-12-30
2010-08-31$1.80M
10-Q · filed 2011-09-30
2010-05-31$6.26M
10-K · filed 2012-07-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93